Physician profile
Deanna Doyle
NPI 1619977451
$567.96
in general payments reported to CMS, 2019-2025
16 companies · $44.64 in 2025
The $44.64 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.88 · 2020: $103 · 2021: $34.82 · 2022: $159 · 2023: $133 · 2025: $44.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $115.11 | 2019-2023 | |
| Hologic Sales and Service, LLC | $114.46 | 2020-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Dysis Medical, INC. | $75.91 | 2020 | |
| Astellas Pharma US INC | $68.36 | 2022-2023 | Veozah |
| Merck Sharp & Dohme LLC | $36.04 | 2019-2020 | |
| Minerva Surgical, INC | $24.49 | 2022 | |
| Coopersurgical, INC. | $20.06 | 2023 | Summit Doppler |
| Allergan, INC. | $17.04 | 2019 | |
| Therapeuticsmd, INC. | $15.83 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.45 | 2019 | |
| Coloplast Corp | $14.25 | 2022 | |
| Medicem INC. | $13.65 | 2022 | |
| Lupin INC. | $13.35 | 2019 | |
| Evofem Biosciences, INC. | $13.14 | 2022 | |
| Aspira Women'S Health INC | $11.82 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.